At a glance
- Originator Takeda
- Class Antiasthmatics
- Mechanism of Action Endothelin receptor antagonists; Leukotriene receptor antagonists; Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma